Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Verifiedinfo

Borvo Clinic Kft.

Hungary Erzsebet Utca 11-13, 4025 Debrecen, Hungary

  • 1 trial recruiting
  • Obesity · Arteriosclerosis · Overweight
  • Adult patients

About Specializations

Borvo Clinic Kft. in Debrecen, Hungary specialises in clinical trials of conditions such as Obesity, Arteriosclerosis, Overweight, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases

The research at Borvo Clinic Kft. targets Atherosclerotic cardiovascular disease (ASCVD) in patients who are also overweight or obese, evaluating a new therapy to improve heart health outcomes.

  • Reducing cardiovascular morbidity and mortality
  • Testing an adjunct to standard of care
  • Assessing impact on individuals with excess weight

This work aims to demonstrate that Maridebart Cafraglutide can provide superior protection against heart events compared with placebo.

Nutritional and Metabolic Diseases

Studies conducted at the clinic focus on obesity and its link to diabetes, exploring a novel injectable to help patients lose weight and improve blood sugar control.

  • Achieving meaningful weight reduction
  • Lowering hemoglobin A1c (HbA1c) levels
  • Ensuring safety for overweight individuals

The trial evaluates the effectiveness of KAI-9531 as a new option for managing body weight and glycemic health.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Erzsebet Utca 11-134025 DebrecenHungary
Open in maps ↗
Recruiting now
1 trial
Conditions studied
3
Partner status
Verified

More sites in DebrecenHungary

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Arteriosclerosis

Recruiting
Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

Obesity

Not yet recruiting
Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

Obesity+1

Not recruiting
Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.